Curis To Continue Focus On Oncology After Wyeth Ends Hedgehog Venture
This article was originally published in The Pink Sheet Daily
Executive Summary
Cambridge, Mass.-based Curis seeks a new partner to continue small molecule and protein hedgehog agonist development in cardiovascular/nervous system disorders.